Tag | Content |
---|
EnhancerAtlas ID | HS044-03380 |
Organism | Homo sapiens |
Tissue/cell | Fetal_kidney |
Coordinate | chr12:69004830-69006880 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Mecom | MA0029.1 | chr12:69006275-69006289 | TAGATAAGATAACC | + | 6.65 | NKX2-5 | MA0063.2 | chr12:69006449-69006459 | ACCACTTGAG | + | 6.02 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_13734 | chr12:69003145-69009054 | CD34_Primary_RO01536 | SE_18704 | chr12:69003120-69009642 | CD4p_CD25-_Il17-_PMAstim_Th | SE_20573 | chr12:69003393-69009603 | CD56 | SE_22652 | chr12:69003206-69009499 | CD8_primiary | SE_25211 | chr12:69004014-69007094 | Colon_Crypt_3 | SE_62856 | chr12:69003173-69035796 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAGTGAGTGC GTGGCCGCTG AGGGAAGCCG CGGCGGCGGC CGCGCGGGGC CGGGCGCCGG 60 CTGAGGGGAG CGGGTGGGGT GCGGCGAGGC GCGGGCCGGG CGCGGCGGTC AGGGGCCCCG 120 GCGGCGGCAG CCCCTCGGCG CGCGGCAGGT GGCGCGAGGG CCAGGCGCCG GGCCCGCGAG 180 CGCGCTGCCT TGCGGGCCGG CGAGGAGGAG CAGCCGCCGC CGCCGCGGGA GAACAGCGCG 240 CTTTGCGGAA GGGGTCAAAT GTCTGAAATA TGGCGGAGGA AGTGAGAGCC CGAGGACCCC 300 CCCACCCGCC CGCTCTCTTC AGCCCGCGTC CGCCGCAGCT TCTCCCGCCG CCCTCCTTTC 360 CCCGCCGGCT CCCCCGAAGA CTCGCTCCCC GCCCCGAGCC CCCTCGCTTG TCGCCTGGGT 420 TCCCTCCGTG GTATGGGTGG AAGTTAGAAC GGAAACCAGA AAGTTGTCCT TTGCGAAGAC 480 CTAGCTTCTC CCAGCCCCGA GCTAGGGCGA GGAGCCTTCG GGGGAAACCA CTCCCAGGCG 540 CCCCGCGGGC TTGAGCCTGA CAGCGAAAAA GTTTGCCTGA AACGGGGCTT GCTTGCTCCA 600 TTTGTTGCGG GAAGTGGCAG GAGGAAGGCA GCGGAGAGAG CCCCACTTAG TCTGGCAGCA 660 GCCACCGTGT AGAGAAAAAC TGTTAAAGGG GCCTTTCCCT TCGTCAGCAA GAGGAAATCT 720 CTTTCTCTTA GAGGGAGAGA AAATCCAGGA AGTTTGTCCT CTTCTCTTTT TCGCCATCTC 780 GAGGTGTCTA ATCCTAAAAC TATCAGCGCC ATGAATTTTA TTTAAAACTA CGCCCAGTGA 840 ACCGGGCTCT CCGGATTTTT CTTCTGAAAA ACACTGATGT CTTTTGGAGA AAAGATCATT 900 TTTGCAAGTT AAAGCAGATG GTTTCCTTCC CCTTCGCTTT CCCCCCTCTC CCACTCTCTT 960 TAATAGTTTA GAAAAACATT TTGGCCCTGT AACTTCTGAT TGGTATGAAT AGAAGCAGTT 1020 CTGTGTTGCA GTAAGGGGAA ATCACATTTT TACGGGGTAG AAAGTTGACA CTAAATGAAG 1080 ATTGTGATTT TAGTATTTTA AAATTAATTC CGTCTAATTG GATTTTGGTT TTGCAGGCAG 1140 CATCTCATAT ATGTCGAGTA CTTAACAATT TAAAGCTCTG ACTTGTAAAT TTATTTTTCA 1200 GCTCTCTTTT TTCGTAATTA GAATACTGTT TGGACTTGCT CAACAAGACC TTATCTTAAC 1260 AAAAAGTAAC TTATAGAAAA GGGAGACATT CATTTAACTT CAAGCCCATA TTATTCTTAA 1320 AAGCTGACTC TTGAAATAGT ATTTATTGAG TCATAGTGGA GTCATGGGAC TTTTTAAGGG 1380 CCGGAAGGGA CTATTTAGAT CATCCAGTCC CACCCTGTCA TTTTATGGAG GAGGAAACTG 1440 AGGCCTAGAT AAGATAACCA GTTAGTGGGT CCACTGACCT TTAGGACAGT AGTCTATCCG 1500 TAAGAGACAA CATGGAGAAA GAAATACAAC GTTTTTATAG TGAATTATCA TCTTACAAAG 1560 AATATTCTTC CCATATCGCA CTTTTAAAAA GTGGGTACCT TAGTCAAATA GGAGAAAAAA 1620 CCACTTGAGT AGTTTCATCC TCAGGTTTTA GGTGAGGAAA CTGATACTCA GATTAAATAA 1680 CTTTAAGCAC ACAGAGCCTG AATGATAGTC TTATTTGAGC TCATCTGTGC TTTTAATGTG 1740 TACTACGTTA GGTGTTTTCA CTTGCATTTC CTTTAGTCTT ATTTGAGCTC ATCTGTGCTT 1800 TTAATGTGTA CTACGTTAGG TGTTTTCACT TGCATTTCCT TGTTTGACGT TGACAATAAA 1860 TCGTGAAGCT GCCTTATCTA AGGAAGTCCT AAAGTAAATC ATTGGAACAC ATGTAGCCAG 1920 TTTGTTGTTT TTAATATGCC AGGTATCAAA ATATAACTGA AGAACCAATG CTAAACTGAC 1980 TTAATTTTAA AATGTTGTAT GGGGCATGAA AATGATTGCT CTGGCTGGGC GTGGTGGTTT 2040 ACGCCTGTAA 2050
|